Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers

Authors

  • Mei Wu PhD;,

    1. Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
    Search for more papers by this author
  • Zhi-fen Wu MD;,

    1. Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
    Search for more papers by this author
  • Devin T. Rosenthal BS;,

    1. Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
    Search for more papers by this author
  • Elliot M. Rhee BS,

    1. Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
    Search for more papers by this author
  • Sofia D. Merajver MD, PhD

    Corresponding author
    1. Department of Internal Medicine, Division of Hematology and Oncology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
    • University of Michigan Health System, Department of Internal Medicine, Division of Hematology and Oncology, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0948
    Search for more papers by this author
    • Fax: (734) 936-7376


Abstract

BACKGROUND:

The 2 closely related small GTPases, RHOC and RHOA, are involved in mammary gland carcinogenesis; however, their specific roles in determining cancer cell adhesion and invasion have not been elucidated.

METHODS:

RHOA and RHOC are highly homologous, thereby posing a major challenge to study their individual functions in cancer cells. By selectively knocking down these proteins, we have been able to alternatively inhibit RHOC and RHOA, while preserving expression of the other rho protein. Quantitative analyses of the growth patterns and invasion in the aggressive estrogen receptor negative cell lines MDA-231 and SUM149 were carried out on collagen I and Matrigel substrates.

RESULTS:

RHOC, and not RHOA, modulates surface expression and colocalization of α2 and β1 integrins in MDA-MB-231 on collagen I. Neither RHOC or RHOA affected integrin expression in the inflammatory breast cancer cell line SUM149, further highlighting the different regulation of adhesion and motility in inflammatory breast cancer.

CONCLUSIONS:

This work shows that RHOC and RHOA play different roles in cell-matrix adhesion, motility, and invasion of MDA-MB-231 and reaffirms the crucial role of RHOC-GTPase in inflammatory breast cancer cell invasion. Cancer 2010;116(11 suppl):2768–82. © 2010 American Cancer Society.

Ancillary